GSK1349572
-
Catalog number2288-25
-
PricePlease ask
-
Size25 mg
-
-
Alternative_name2H-Pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide, N-[(2,4-difluorophenyl)methyl]-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-, (4R,12aS)-
-
DescriptionA potent, second generation HIV integrase inhibitor (IC₅₀ = 2.7 nM) that displays potent antiviral activity.
-
CAS Number1051375-16-6
-
Structure AvailableYes
-
Peptide sequenceNo
-
Salt FormNo
-
Molecular FormulaC₂₀H₁₉F₂N₃O₅
-
Molecular Weight419.38
-
Cell PermeableYes
-
Purity≥98% by HPLC
-
SolubilitiesDMSO (>80 mg/ml)
-
HandlingProtect from light and moisture
-
Tag LineA potent HIV integrase inhibitor
-
Storage Condition-20 ̊C
-
Shipping Conditiongel pack
-
Shelf Life36 months
-
PubChem CID54726191
-
SMILESCC1CCOC2N1C(=O)C3=C(C(=O)C(=CN3C2)C(=O)NCC4=C(C=C(C=C4)F)F)O
-
InChiInChI=1S/C20H19F2N3O5/c1-10-4-5-30-15-9-24-8-13(17(26)18(27)16(24)20(29)25(10)15)19(28)23-7-11-2-3-12(21)6-14(11)22/h2-3,6,8,10,15,27H,4-5,7,9H2,1H3,(H,23,28)/t10-,15+/m1/s1
-
InChi KeyRHWKPHLQXYSBKR-BMIGLBTASA-N
-
MSDS AvailableYes
-
Gene target
-
Short nameGSK1349572
-
Alternative nameGSK1349572
-